Labcorp has completed the acquisition of Personal Genome Diagnostics, which provides comprehensive genomic products and services based on liquid biopsies and tissue. PGD had revenues of about $22 million in 2021 and is expected to grow to $40 million in 2022. Labcorp paid $450 million for PGD and will pay up to an additional $125 million when certain milestones are reached.